0001104659-22-106053.txt : 20221004
0001104659-22-106053.hdr.sgml : 20221004
20221004213152
ACCESSION NUMBER: 0001104659-22-106053
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220930
FILED AS OF DATE: 20221004
DATE AS OF CHANGE: 20221004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schroeder Theodore R
CENTRAL INDEX KEY: 0001378690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37558
FILM NUMBER: 221294298
MAIL ADDRESS:
STREET 1: 12481 HIGH BLUFF DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nabriva Therapeutics plc
CENTRAL INDEX KEY: 0001641640
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25-28 NORTH WALL QUAY
CITY: DUBLIN
STATE: L2
ZIP: D01 H104
BUSINESS PHONE: (610) 816-6640
MAIL ADDRESS:
STREET 1: 414 COMMERCE DRIVE
STREET 2: STE 120
CITY: FORT WASHINGTON
STATE: PA
ZIP: 19034
FORMER COMPANY:
FORMER CONFORMED NAME: Nabriva Therapeutics AG
DATE OF NAME CHANGE: 20150507
4
1
tm2227483-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-09-30
0
0001641640
Nabriva Therapeutics plc
NBRV
0001378690
Schroeder Theodore R
414 COMMERCE DR.
SUITE 120
FORT WASHINGTON
PA
19034
1
1
0
0
Chief Executive Officer
Ordinary Shares
2022-09-30
4
F
0
5
2.08
D
12474
D
These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.
The number of ordinary shares reported on this Form 4 reflects a 1-for-25 reverse stock split effected on September 15, 2022.
/s/ Dan Dolan, by power of attorney
2022-10-04